A Phase 1b, multicenter, open-label platform study of select drug combinations in adult patients with lower risk (very low, low, or intermediate risk) myelodysplastic syndrome

  • Tiong, Ing Soo (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date1/04/21 → 31/12/25
View all
View less

Keywords

  • Myelodysplastic syndrome
  • Blood cancer
  • Clinical trial